UFC heavyweight Daniel Omielanczuk has been notified by USADA of a potential Anti-Doping violation due to an out-competition drug test he recently submitted.
The potential Anti-Doping violation was announced by the UFC in a statement today.
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) informed Daniel Omielanczuk of a potential Anti-Doping Policy Violation involving Meldonium, a prohibited substance on the World Anti-Doping Agency (WADA) Prohibited List,” the UFC statement said. “USADA further informed UFC that due to recent WADA statements regarding the handling of Meldonium cases, they will not be issuing a provisional suspension to Omielanczuk at this time. Accordingly, Omielanczuk has not been removed from his scheduled bout against Alexy Oleinik in Sioux Falls, South Dakota, on July 13, 2016.”
Omielanczuk (18-5-1, 1NC) has gone 3-2 in the UFC and is currently on a two fight winning streak. His most recent win came in February against Jarjis Danho by technical majority decision.